Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBPR108 in Chinese patients with type 2 diabetes mellitus (phase II)
CTR20170397Phase 2Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prusogliptin in type 2 diabetes mellitus (T2DM), sponsored by CSPC Pharmaceutical Group. Started Jun 2017; status: completed.
02
Drugs
prusogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170397.